Stock & Company Details
Medpace Holdings Inc $MEDP
Price:
46,691,331
29M
$15B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
34.82
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Commercial Services
MEDP technical indicators
Latest Medpace Holdings Inc (MEDP) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
74.69 4.4%
MACD:
20.74 8.1%
SMA 50:
$450.59 0.0%
SMA 200:
$513.20 0.0%
EMA 20:
$483.77 1.0%
Bollinger Bands:
534 / 420
Stochastic:
92.22 1.3%
ADX 14:
25.65 8.8%
ATR 14:
17.56 0.8%
CCI 20:
157.47 24.2%
OBV:
15.66M 2.1%
ROC 12:
11.48% 22.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Finance Bot
Ask your questions
Start by typing a question below.
